WeVote
Log In

Bill

Bill

S 1243

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

2026-2027 Regular Session Introduced by Linda Greenstein and 1 co-sponsor

New Jersey establishes a commission to study Alzheimer's disease impacts and develop a comprehensive state master plan addressing care, services, and resource gaps.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
0
WeVote Research Nonpartisan
Bill Summary · S 1243

Legislative bill overview

S 1243 establishes a commission tasked with developing a comprehensive master plan to address Alzheimer's disease in New Jersey. The commission would study the disease's impact, existing resources, gaps in care and services, and recommend policy solutions for the state.

Why is this important

Alzheimer's disease affects approximately 110,000 New Jersey residents, with cases projected to increase significantly as the population ages. A coordinated state master plan could improve care coordination, identify funding needs, and establish priorities for prevention, treatment, and support services across the healthcare and social service systems.

Potential points of contention

  • Commission composition and expertise: Questions about whether the commission includes adequate representation from patients, caregivers, healthcare providers, and researchers to produce actionable recommendations
  • Timeline and implementation: Uncertainty about when recommendations will be completed and whether the legislature will prioritize funding for recommended initiatives
  • Scope limitations: The bill creates a study commission rather than directly allocating resources, meaning actual improvements depend on future legislative action based on the commission's findings

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.